Multiple Sclerosis Clinical Trial
— MS-ROBOTOfficial title:
Robot-based Assessment and Therapy in the Treatment of Upper Limb Impairment in Multiple Sclerosis: a Multi-center, Randomised Controlled Trial
Verified date | May 2015 |
Source | Fondazione Don Carlo Gnocchi Onlus |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: National Institute of Health |
Study type | Interventional |
Robot-assisted therapy has proven effective in the neuromotor rehabilitation of eg stroke
survivors. Robots can be programmed to interact with patients by guiding their movements, by
monitoring their performance and by quantifying the type and degree of their impairment.
A distinctive element of multiple sclerosis is the involvement of a variety of functional
systems, in a way that is highly subject-specific. This requires a personalization of
treatment, and continuous adaptation to changes in condition. This points to a need for
integrating patient assessment, definition of rehabilitation protocols, their administration
and the assessment of their outcome.
The goal of this study is to assess, in persons with MS, the efficacy of a type of
robot-assisted training that was specifically designed to counteract incoordination and
muscle weakness (typical of MS), tailored to individual type and degree of impairment, when
compared to simple movement training.
Status | Completed |
Enrollment | 41 |
Est. completion date | December 2011 |
Est. primary completion date | July 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion: - definite Multiple sclerosis, stable phase of the disease - no relapses or worsening >1 in the Expanded Disability Status Scale in the last three months, - Expanded Disability Status Scale<7.5, - Ashworth score at the upper limb lower than 2, - Nine-Hole Peg Test between 30 s and 180 s Exclusion: - previous treatment with robot therapy, - presence of severe nystagmus, - visual acuity less than 4/10 - major orthopaedic or other disorders interfering with the protocol |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Fondazione Don Carlo Gnocchi Onlus | Azienda Sanitaria Locale 3 Genovese, University of Genova |
Basteris A, De Luca A, Sanguineti V, Solaro C, Mueller M, Carpinella I, Cattaneo D, Bertoni R, Ferrarin M. A tailored exercise of manipulation of virtual tools to treat upper limb impairment in Multiple Sclerosis. IEEE Int Conf Rehabil Robot. 2011;2011:5975509. doi: 10.1109/ICORR.2011.5975509. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of the 9 Hole Peg Test score | baseline and 4 weeks and baseline and 16 weeks | No | |
Secondary | Treatment change in percentage of responders at 9 Hole Peg Test score | Number of responders i.e. the subjects who experienced an improvement greater than 20% at the 9HPT | baseline and 4 weeks and baseline and 16 weeks | No |
Secondary | Absolute change of exercise performance | Performance score (a combination of a movement duration and a path length component, with equal weights) | baseline and 4 weeks and baseline and 16 weeks | No |
Secondary | Absolute change of task difficulty | Resistive and mass-spring stiffness (Haptic group only) | baseline and 4 weeks and baseline and 16 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|